Delivery of the Report will take 2-3 working days once order is placed.
Synopsis
Hyoscine-N-Butyl Bromideis obtained from a species of the plant genus Duboisia. It is mainly classified as an antispasmodic, which means that it is a drug used to suppress of muscle spasms, or involuntary contractions.
It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms.
Scope of the Report:
This report focuses on the Hyoscine-N-Butyl Bromide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Hyoscine-N-Butyl Bromideis obtained from a species of the plant genus Duboisia. It is mainly classified as an antispasmodic, which means that it is a drug used to suppress of muscle spasms, or involuntary contractions.
The production of Hyoscine-N-Butyl Bromideis increased from 6.3 MT in 2012 to 6.9 MT in 2016, at a CARG 2.54%. The manufacturers are Boehringer-Ingelheim, Linnea, Alchem International and Alkaloids.
Boehringer-Ingelheim is the world leader with 77.62% of market share in 2016. Boehringer-Ingelheim produces both Hyoscine-N-Butyl Bromideis API and Buscopan. They mainly sale Buscopan in market and the revenue of Buscopan is 236 EUR million and the revenue of Hyoscine-N-Butyl Bromideis API is 30.2 million USD in 2016.
The worldwide market for Hyoscine-N-Butyl Bromide is expected to grow at a CAGR of roughly 6.0% over the next five years, will reach 57 million US$ in 2023, from 40 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Boehringer-Ingelheim
- Linnea, Alchem International
- Alkaloids
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Boehringer-Ingelheim
- Linnea
- Alchem International
- Alkaloids
Market Segment by Applications, can be divided into
- Oral
- Injection
There are 15 Chapters to deeply display the global Hyoscine-N-Butyl Bromide market.
Chapter 1, to describe Hyoscine-N-Butyl Bromide Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Hyoscine-N-Butyl Bromide, with sales, revenue, and price of Hyoscine-N-Butyl Bromide, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Hyoscine-N-Butyl Bromide, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Hyoscine-N-Butyl Bromide market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Hyoscine-N-Butyl Bromide sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source